Crossmark

The subjective minimal important change for the Six Spot Step Test in people with multiple sclerosis - The Danish MS Hospitals Rehabilitation study

Published Online: 2022-06-15

Published Print: 2022-08

Authors

Pommerich, Uwe M. https://orcid.org/0000-0003-1313-2056
Brincks, John https://orcid.org/0000-0002-8788-1669
Skjerbæk, Anders Guldhammer https://orcid.org/0000-0001-5924-2934
Dalgas, Ulrik https://orcid.org/0000-0003-4132-2789
License Information

Text and Data Mining valid from 2022-06-15

Version of Record valid from 2022-06-15
More Information

Article History

Received: 5 October 2021

Accepted: 24 May 2022

First Online: 15 June 2022

Declarations

:

: Ulrik Dalgas has received research support, travel grants and/or teaching honorary from Biogen Idec, Merck Serono, Novartis, Bayer Schering and Sanofi Aventis as well as honoraria from serving on scientific advisory boards of Biogen Idec and Genzyme. The other authors report no conflict of interest.

: The current study is a secondary analysis of data from the Danish MS Hospitals Rehabilitation study; the main study was organised to meet the standards of the Helsinki declaration and was approved by the research ethics committee of the Zealand region (ref.no. 1-01-83-0002-07) and the Danish Data Protection Agency (ref. no. 2011-41-6751). All participants provided informed consent prior to inclusion. In addition, the main study was registered in the ISRCTN registry: . The consensus standards of the selection of health status measurement instruments (COSMIN) framework was used in this investigation.

Document is current